Givaudan completes the acquisition of Soliance
- Strengthens process development and research capabilities
- Building on existing Givaudan active cosmetic ingredients business and enhancing current portfolio offering
Geneva, 3 June 2014 | Givaudan announced today that it has acquired 100% of the shares of Soliance SA and its subsidiaries. Soliance provides innovative cosmetic solutions to its international clients and partners and develops high added-value active ingredients, derived from vegetable sources, microorganisms and microalgae. Soliance currently has two sites in France, located in Pomacle and Ile Grande, and employs 96 people.
Gilles Andrier, CEO of Givaudan, said: “Soliance represents Givaudan’s first acquisition since that of Quest. Its current portfolio of active cosmetic ingredients and strong process development and research capabilities fit well into the five strategic pillars of Givaudan.”
Michael Carlos, President of Givaudan’s Fragrance Division, said: “Soliance will become an integral part of the Fragrance Division and bring significant contributions over the next few years, with its capabilities in innovation and mastering of advanced technologies. Soliance has a strong track record of identifying natural and unique molecules which can bring value to our customers and to their consumers.”
While terms of the deal have not been disclosed, the Soliance operations would have represented approximately CHF 25 million of incremental sales to Givaudan’s results in 2013 on a proforma basis. Givaudan will fund the transaction from existing resources.
Soliance is a French company which has developed, produced and sold active ingredients to the cosmetic industry since 1994. The company provides innovative cosmetic solutions to its international clients and partners and develops high added-value ingredients, derived from vegetable sources, microorganisms and microalgae. Soliance is an ethical company with high standards and eco-design products. Its strength in sustainable development is a major contribution to the cosmetic industry. More information can be found at http://www.soliance.com/.
For further information please contact:
Peter Wullschleger, Givaudan Media and Investor Relations
Chemin de la Parfumerie 5
T +41 22 780 9093
F +41 22 780 9090